Physician

Khalid S Kahook, M.D.,

According to 2025 Medicare claims, Khalid Kahook, M.D., (NPI: 1356640726) practices ophthalmology in the Fond du Lac, WI market, with the plurality of this provider's patient population coming from Fond Du Lac, WI. This provider's primary affiliated billing organization is NORTHEAST WISCONSIN RETINA ASSOCIATES SC (NPI: 1437164175; TIN: 391842462) and primary practice location at 54482-8483.

Kahook's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 619 traditional Medicare patients, billed 20,531 HCPCS/CPT codes, and received $2,145,035 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 232 prescription claims across 73 beneficiaries totaling $8,983 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $63. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $244,037 to $2,145,035. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,391 and ending at $8,983. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2016 Medicare payment: $244,037 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,143,287 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,482,126 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,722,423 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,799,522 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,868,808 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,972,870 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,934,052 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,145,035 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162221,856$244,037
20175077,219$1,143,287
20185548,356$1,482,126
20195317,392$1,722,423
20205787,226$1,799,522
20216217,951$1,868,808
202258910,319$1,972,870
202361316,166$1,934,052
202461920,531$2,145,035

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$21K2015 Drug cost: $10,391 (USD; Tot_Drug_Cst)2016 Drug cost: $2,474 (USD; Tot_Drug_Cst)2017 Drug cost: $14,469 (USD; Tot_Drug_Cst)2018 Drug cost: $21,481 (USD; Tot_Drug_Cst)2019 Drug cost: $18,453 (USD; Tot_Drug_Cst)2020 Drug cost: $16,988 (USD; Tot_Drug_Cst)2021 Drug cost: $20,772 (USD; Tot_Drug_Cst)2022 Drug cost: $19,019 (USD; Tot_Drug_Cst)2023 Drug cost: $15,084 (USD; Tot_Drug_Cst)2024 Drug cost: $8,983 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201538168$10,391
20163264$2,474
201793305$14,469
2018113407$21,481
201993300$18,453
202092258$16,988
202198289$20,772
202282248$19,019
202373214$15,084
202473232$8,983

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1781,656$648
67028Injection of drug into eye2811,501$87
92014Established patient complete exam of visual system265309$83
J9035Injection, bevacizumab, 10 mg113454$55
92134Imaging of retina6102,084$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate361,507$1,914
DifluprednateDifluprednate16369$1,303
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat412,649$572
Ketorolac TromethamineKetorolac Tromethamine16501$358
Dorzolamide HclDorzolamide Hcl22719$347

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$63Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Khalid S. Kahook, M.D., ?

Tedicare shows public-source Medicare data for Khalid S. Kahook, M.D., (NPI 1356640726), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khalid S. Kahook, M.D., have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Khalid S. Kahook, M.D., ?

Khalid S. Kahook, M.D., is linked to NORTHEAST WISCONSIN RETINA ASSOCIATES SC (billing NPI 1437164175) in the available physician profile data.

Does Khalid S. Kahook, M.D., have Open Payments data?

Khalid S. Kahook, M.D., has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.